Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 4701-4750 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT07132918
HEARTS Trial for Thoracic Cancers
PHASE2
Recruiting
60 participants
Started: Oct 8, 2025 · Completed: Mar 31, 2029
5 conditions
2 sponsors
1 location
NCT07215078
Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants
PHASE1
Not yet recruiting
72 participants
Started: Oct 8, 2025 · Completed: May 7, 2026
1 condition
1 sponsor
1 location
NCT07173959
Digital Therapy for Individualized Intervention and Management of Gestational Diabetes Mellitus
NA
Not yet recruiting
160 participants
Started: Oct 8, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
0 locations
NCT07103018
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
PHASE1
Recruiting
144 participants
Started: Oct 8, 2025 · Completed: Sep 30, 2028
5 conditions
1 sponsor
2 locations
NCT07104084
Influence of Antiseptic Washes on Wound Healing Complications After THA
NA
Recruiting
420 participants
Started: Oct 8, 2025 · Completed: Jan 1, 2028
2 conditions
2 sponsors
2 locations
NCT07201597
Correlation Between Psychological Readiness, Knee Function, and Isokinetic Performance After Anterior Cruciate Ligament Reconstruction (ACLR) Using Peroneus Longus Tendon Graft (PL-ACL-2025)
N/A
Recruiting
52 participants
Started: Oct 8, 2025 · Completed: Nov 1, 2025
3 conditions
2 sponsors
1 location
NCT07200336
Anti-IL-5 Therapy With Simple Polypectomy Versus Extended Endoscopic Sinus Surgery for CRSwNP
PHASE4
Not yet recruiting
360 participants
Started: Oct 8, 2025 · Completed: Oct 10, 2031
1 condition
1 sponsor
17 locations
NCT07200830
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
PHASE3
Not yet recruiting
1,524 participants
Started: Oct 8, 2025 · Completed: Sep 9, 2034
3 conditions
2 sponsors
0 locations
NCT07213206
CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer
PHASE3
Not yet recruiting
1,500 participants
Started: Oct 7, 2025 · Completed: Sep 1, 2035
1 condition
1 sponsor
0 locations
NCT07213349
Daridorexant for Alzheimer Disease Prevention
PHASE2
Not yet recruiting
240 participants
Started: Oct 7, 2025 · Completed: Dec 31, 2029
1 condition
2 sponsors
1 location
NCT07204158
Evaluation of a Medical Device Based on Isotonic Seawater and Hyaluronic Acid Used as a Nasal Spray
NA
Not yet recruiting
65 participants
Started: Oct 7, 2025 · Completed: Feb 28, 2026
1 condition
2 sponsors
0 locations
NCT07160530
Healthy Children, Healthy Communities: Effectiveness of a Multilevel Rural Community Engagement Model for Improving Children's Dietary Intake in Family Child Care Homes
NA
Recruiting
360 participants
Started: Oct 7, 2025 · Completed: May 31, 2029
5 conditions
1 sponsor
1 location
NCT06899126
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
PHASE3
Recruiting
686 participants
Started: Oct 7, 2025 · Completed: Jul 5, 2032
1 condition
2 sponsors
26 locations
NCT07149350
Food Access, Value, and Optimization of Resources
NA
Enrolling by invitation
40 participants
Started: Oct 7, 2025 · Completed: Nov 30, 2027
4 conditions
1 sponsor
1 location
NCT04119024
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
PHASE1
Recruiting
18 participants
Started: Oct 7, 2025 · Completed: Oct 31, 2026
17 conditions
6 sponsors
2 locations
NCT07100106
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
PHASE1/PHASE2
Recruiting
285 participants
Started: Oct 7, 2025 · Completed: Jul 31, 2030
1 condition
2 sponsors
5 locations
NCT06836284
The Evira Study: Additional Support During Anti-Obesity Treatment
NA
Not yet recruiting
40 participants
Started: Oct 7, 2025 · Completed: Oct 31, 2026
2 conditions
2 sponsors
1 location
NCT07219121
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
PHASE4
Recruiting
20 participants
Started: Oct 7, 2025 · Completed: May 31, 2027
4 conditions
1 sponsor
3 locations
NCT06649812
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
PHASE2
Recruiting
120 participants
Started: Oct 7, 2025 · Completed: Sep 1, 2027
15 conditions
1 sponsor
48 locations
NCT07140900
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
PHASE1
Recruiting
60 participants
Started: Oct 7, 2025 · Completed: Mar 30, 2030
1 condition
1 sponsor
4 locations
NCT07198464
Relmacabtagene Autoleucel Combined With Autologous Hematopoietic Stem Cell Transplantation, Orelabrutinib, and Sintilimab for Primary Central Nervous System Lymphoma
NA
Not yet recruiting
30 participants
Started: Oct 7, 2025 · Completed: Oct 1, 2029
1 condition
1 sponsor
0 locations
NCT07023666
Early Screening and Treatment of Heart Complication in Sickle Cell Disease
PHASE2
Recruiting
100 participants
Started: Oct 7, 2025 · Completed: Jun 30, 2027
1 condition
1 sponsor
2 locations
NCT07133191
A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants
PHASE1
Enrolling by invitation
32 participants
Started: Oct 7, 2025 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT07070219
A Study of CTD402 in T-ALL/LBL Patients
PHASE1/PHASE2
Recruiting
54 participants
Started: Oct 7, 2025 · Completed: Dec 30, 2028
2 conditions
1 sponsor
4 locations
NCT07215351
Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women
NA
Recruiting
30 participants
Started: Oct 7, 2025 · Completed: Jan 1, 2026
2 conditions
2 sponsors
1 location
NCT07216443
Reduced Intensity or Nonmyeloablative Conditioning With Orca-T for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
PHASE2
Recruiting
80 participants
Started: Oct 7, 2025 · Completed: Dec 31, 2028
3 conditions
1 sponsor
4 locations
NCT06988488
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
PHASE1/PHASE2
Recruiting
62 participants
Started: Oct 7, 2025 · Completed: Jun 3, 2027
1 condition
1 sponsor
22 locations
NCT07215104
A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) for the Treatment of Chronic Low Back Pain
NA
Recruiting
30 participants
Started: Oct 7, 2025 · Completed: Jan 1, 2027
1 condition
2 sponsors
1 location
NCT07116057
MOv19-BBz CAR T Cells in FRa+ Cancers
PHASE1
Recruiting
10 participants
Started: Oct 7, 2025 · Completed: Oct 31, 2040
2 conditions
2 sponsors
1 location
NCT06961630
Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction
EARLY_PHASE1
Recruiting
50 participants
Started: Oct 7, 2025 · Completed: Mar 31, 2027
1 condition
2 sponsors
1 location
NCT07188467
Testing Adapted Self-Help Plus (SH+) for Stress and Well-Being in International Students at a U.S. University
NA
Recruiting
50 participants
Started: Oct 7, 2025 · Completed: Jan 31, 2026
4 conditions
1 sponsor
1 location
NCT07214870
A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat
PHASE1
Not yet recruiting
60 participants
Started: Oct 7, 2025 · Completed: May 14, 2027
1 condition
1 sponsor
1 location
NCT07201545
Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin
PHASE1
Not yet recruiting
58 participants
Started: Oct 7, 2025 · Completed: Nov 26, 2025
1 condition
1 sponsor
1 location
NCT07212647
Home-Based Strategies for Knee Osteoarthritis
NA
Enrolling by invitation
100 participants
Started: Oct 6, 2025 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT07191691
Observational Study of Psychomotor Development in Children Born in France to Parents Born in Sub-Saharan Africa.
N/A
Not yet recruiting
240 participants
Started: Oct 6, 2025 · Completed: Sep 30, 2027
3 conditions
1 sponsor
1 location
NCT06637293
Deployment and Evaluation of Artificial Intelligence Software for Electrocardiogram Analysis and Management in Primary Care
NA
Not yet recruiting
2,000 participants
Started: Oct 6, 2025 · Completed: Mar 31, 2027
2 conditions
1 sponsor
1 location
NCT07079280
Comparing Vascular Responses to Aerobic Exercise With and Without Blood Flow Restriction in Young and Older Adults
NA
Not yet recruiting
52 participants
Started: Oct 6, 2025 · Completed: Jul 31, 2026
2 conditions
1 sponsor
1 location
NCT07208331
Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management
N/A
Not yet recruiting
750 participants
Started: Oct 6, 2025 · Completed: Oct 1, 2030
3 conditions
2 sponsors
1 location
NCT07207954
Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis
PHASE1
Not yet recruiting
176 participants
Started: Oct 6, 2025 · Completed: Jul 16, 2027
1 condition
1 sponsor
7 locations
NCT06965530
Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy
NA
Recruiting
360 participants
Started: Oct 6, 2025 · Completed: May 31, 2029
3 conditions
5 sponsors
2 locations
NCT06733376
Evaluating Evidenced Based Options for PTSD Treatment
NA
Recruiting
400 participants
Started: Oct 6, 2025 · Completed: Jun 1, 2030
1 condition
1 sponsor
1 location
NCT07161258
A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
PHASE2
Recruiting
12 participants
Started: Oct 6, 2025 · Completed: Feb 13, 2029
1 condition
1 sponsor
6 locations
NCT07214896
Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings
PHASE2
Enrolling by invitation
400 participants
Started: Oct 6, 2025 · Completed: Oct 6, 2031
4 conditions
1 sponsor
4 locations
NCT07189468
AI-based Progression and Medication Response Prediction Study in Parkinson's Disease
N/A
Not yet recruiting
100 participants
Started: Oct 6, 2025 · Completed: Apr 1, 2027
1 condition
2 sponsors
4 locations
NCT07073638
Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis
PHASE2
Not yet recruiting
24 participants
Started: Oct 6, 2025 · Completed: Nov 15, 2026
1 condition
1 sponsor
1 location
NCT05179408
Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer
NA
Not yet recruiting
40 participants
Started: Oct 6, 2025 · Completed: Mar 30, 2027
2 conditions
1 sponsor
1 location
NCT07189858
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada
NA
Not yet recruiting
4,740 participants
Started: Oct 6, 2025 · Completed: Dec 31, 2025
4 conditions
1 sponsor
0 locations
NCT07189533
SENior PRIorat: Participatory Research for the Improvement of Lifestyles, Quality of Life, Emotional Well-being, and Locomotor Abilities of Older Adults in the Priorat
NA
Not yet recruiting
80 participants
Started: Oct 6, 2025 · Completed: Apr 30, 2027
1 condition
3 sponsors
1 location
NCT06914622
Real-time Experiences, Physical Activity and Biological Outcomes in Personal Recovery Residents (EMPOWER-RES)
NA
Not yet recruiting
60 participants
Started: Oct 6, 2025 · Completed: Dec 31, 2028
2 conditions
1 sponsor
0 locations
NCT06882174
This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung Cancer
PHASE2
Not yet recruiting
58 participants
Started: Oct 6, 2025 · Completed: Dec 31, 2027
1 condition
1 sponsor
0 locations
Previous
1
More pages
92
93
94
95
96
97
98
More pages
2369
Next